Cencora International Healthcare Solutions — Accumulated impairment losses increased by 146.6% to $1.22B in Q3 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates that the company has recognized significant declines in the value of its international acquisitions, suggesting past strategic missteps or adverse changes in foreign market conditions. A stable or zero balance suggests that the segment's assets are performing in line with or above their original acquisition valuations.
This metric represents the total historical value of write-downs recognized against the carrying value of goodwill and i...
Peers in the pharmaceutical distribution and global logistics space report similar figures under 'Goodwill Impairment' or 'Asset Impairment' charges, which are often compared against total segment goodwill to assess the risk of future write-downs.
cor_segment_international_healthcare_solutions_accumulated_impairment_losses| Q3 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|
| Value | $75.94M | $493.94M | $1.22B |
| QoQ Change | — | +550.5% | +146.6% |
| YoY Change | — | +550.5% | +146.6% |